Petra Tesařová

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

Petra Tesařová, Marta Kalousová, M Jáchymová et al. · Cancer Investigation · 2007 · 113 citations

Medicine, Cancer Biology, Oncology +15

Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor–Positive, <i>ERBB2</i>-Negative Advanced Breast Cancer

Antonio Llombart‐Cussac, José Manuel Pérez-García, Meritxell Bellet et al. · JAMA Oncology · 2021 · 106 citations · Full text

Medicine, Oncology, Pharmacology +16

The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: First-year results from the Compliance of ARomatase Inhibitors AssessmenT In Daily practice through Educational approach (CARIATIDE) study

Patrick Neven, Christos Markopoulos, Minna Tanner et al. · The Breast · 2014 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17

Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease?

Petra Tesařová, Marta Kalousová, B Trnková et al. · PubMed · 2007 · 47 citations

Medicine, Cancer Biology, Oncology +17

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

Camillo Porta, Aristotelis Bamias, Farhad R. Danesh et al. · Kidney International · 2020 · 46 citations · Full text

Medicine, Nephrology, Oncology +17